SIGIRR, a negative regulator of Toll-like receptor - Interleukin 1 receptor signaling

Nature Immunology

Volumn 4, Issue 9, 2003, Pages 920-927

  Wald, David ^a   Qin, Jinzhong ^a   Zhao, Zhendong ^a   Qian, Youcun ^a   Naramura, Mayumi ^a   Tian, Liping ^a   Towne, Jennifer ^b   Sims, John E ^b   Stark, George R ^a   Li, Xiaoxia ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; LIGAND; PROTEIN SIGIRR; REGULATOR PROTEIN; SINGLE IMMUNOGLOBULIN INTERLEUKIN 1 RECEPTOR RELATED PROTEIN; SYNAPSIN I; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEFICIENCY; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INDUCTION; PROVOCATION TEST; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; CHEMOKINES; GENE EXPRESSION REGULATION; HUMANS; IMMUNOBLOTTING; INTERLEUKIN-1; INTERLEUKIN-18; JURKAT CELLS; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; RECEPTORS, CELL SURFACE; RECEPTORS, INTERLEUKIN-1; RNA; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTOR AP-1;

EID: 0042733592     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni968     Document Type: Article

References (36)

1. Dinarello, C. A. Interleukin-1. Cytokine Growth Factor Rev. 8, 253-265 (1997).
2. Neumann, D., Kollewe, C., Martin, M.U. & Boraschi, D. The membrane form of the type II IL-1 receptor accounts for inhibitory function. J. Immunol. 165, 3350-3357 (2000).
3. Akira, S. The role of IL-18 in innate immunity. Curr. Opin. Immunol. 12, 59-63 (2000).
4. Townsend, M.J., Fallon, P.G., Matthews, D.J., John, H.E. & McKenzie, A.N. T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J. Exp. Med. 191, 1069-1076 (2000).
5. Alexopoulou, L., Holt, A.C., Medzhitov, R. & Flavell, R.A. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413, 732-738 (2001).
6. Takeuchi, O. et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11, 443-451 (1999).
7. Ozinsky, A. et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl. Acad. Sci. USA 97, 13766-13771 (2000).
8. Hemmi, H. et al. A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745 (2000).
9. Hayashi, F. et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410, 1099-1103 (2001).
10. Hoshino, K. et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162, 3749-3752 (1999).
11. Dunne, A. & O'Neill, L.A. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci. STKE 2003, re3(2003).
12. Muzio, M., Ni, J., Feng, P. & Dixit, V.M. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 278, 1612-1615 (1997).
13. Wesche, H., Henzel, W.J., Shillinglaw, W., Li, S. & Cao, Z. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7, 837-847 (1997).
14. Burns, K. et al. MyD88, an adapter protein involved in interleukin-1 signaling. J. Biol. Chem. 273, 12203-12209 (1998).
15. Cao, Z., Henzel, W.J. & Gao, X. IRAK: a kinase associated with the interleukin-1 receptor. Science 271, 1128-1131 (1996).
16. Li, S., Strelow, A., Fontana, E.J. & Wesche, H. IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Proc. Natl. Acad. Sci. USA 99, 5567-5572 (2002).
17. Jiang, Z. et al. Pellino 1 is required for Interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complex. J. Biol. Chem. 278, 10952-10956 (2003).
18. Jiang, Z., Ninomiya-Tsuji, J., Qian, Y., Matsumoto, K. & Li, X. Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol. Mol. Cell. Biol. 22, 7158-7167 (2002).
19. Takaesu, G. et al. Interleulkin-1 (IL-1) receptor-associated kinase leads to activation of TAK1 by inducing TAB2 translocation in the IL-1 signaling pathway. Mol. Cell. Biol. 21, 2475-2484 (2001).
20. Regnier, C.H. et al. Identification and characterization of an IκB kinase. Cell 90, 373-383 (1997).
21. Mercurio, F. et al. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 278, 860-866 (1997 ).
22. Jiang, Z. et al. Poly I:C-induced TLR3-mediated activation of NF-κB and MAP kinases is through an IRAK-independent pathway employing signaling components TLR3-TRAF6-TAK1-TAB2-PKR. J. Biol. Chem. 278, 16713-16719 (2003).
23. Yamamoto, M. et al. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-β promoter in the Toll-like receptor signaling. J. Immunol. 169, 6668-6672 (2002).
24. Imler, J.L. & Hoffmann, J.A. Toll signaling: the TIReless quest for specificity. Nat. Immunol. 4, 105-106 (2003).
25. Glauser, M.P. Pathophysiologic basis of sepsis: considerations for future strategies of intervention. Crit. Care. Med. 28, S4-8 (2000).
26. Ardizzone, S. & Porro, G.B. Inflammatory bowel disease: new insights into pathogenesis and treatment. J. Intern. Med. 252, 475-496 (2002).
27. Bingham, C.O., III. The pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and inflammation. J. Rheumatol. Suppl. 65, 3-9 (2002).
28. Kobayashi, K. et al. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110, 191-202 (2002).
29. Burns, K. et al. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J. Exp. Med. 197, 263-268 (2003).
30. Janssens, S., Burns, K., Tschopp, J. & Beyaert, R. Regulation of interleukin-1- and lipopolysaccharide-induced NF-κB activation by alternative splicing of MyD88. Curr. Biol. 12, 467-471 (2002).
31. Thomassen, E., Renshaw, B.R. & Sims, J.E. Identification and characterization of SIGIRR, a molecule representing a novel subtype of the IL-1R superfamily. Cytokine 11, 389-399 (1999).
32. Cao, Z., Xiong, J., Takeuchi, M., Kurama, T. & Goeddel, D.V. TRAF6 is a signal transducer for interleukin-1. Nature 383, 443-446 (1996).
33. Saccani, S., Polentarutti, N., Penton-Rol, G., Sims, J.E. & Mantovani, A. Divergent effects of LPS on expression of IL-1 receptor family members in mononuclear phagocytes in vitro and in vivo. Cytokine 10, 773-780 (1998).
34. Penton-Rol, G. et al. Bacterial lipopolysaccharide causes rapid shedding, followed by inhibition of mRNA expression, of the IL-1 type II receptor, with concomitant up-regulation of the type I receptor and induction of incompletely spliced transcripts. J. Immunol. 162, 2931-2938 (1999).
35. Mosley, B. et al. The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell 59, 335-348 (1989).
36. Mitchell, T. & Sugden, B. Stimulation of NF-κB-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J. Virol. 69, 2968-2976 (1995).